NCT00004042View on ClinicalTrials.gov

Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 30, 1998

Primary Completion Date

July 31, 2001

Study Completion Date

December 31, 2009

Conditions
Colorectal Cancer
Interventions
BIOLOGICAL

monoclonal antibody F19

RADIATION

iodine I 131 monoclonal antibody F19

Trial Locations (3)

2006

Ludwig Institute for Cancer Research-Sydney Branch, Sydney

10021

Memorial Sloan-Kettering Cancer Center, New York

55905

Mayo Clinic Cancer Center, Rochester

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00004042 - Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic Cancer | Biotech Hunter | Biotech Hunter